How Theranos Fooled Everyone by Skipping First Principles

The Challenge

Theranos's promise was revolutionary: run comprehensive blood tests from a single drop of blood using a device called the Edison. If true, it would transform healthcare — making blood testing faster, cheaper, and less painful.

The problem: the laws of chemistry and physics made this extremely difficult. Most blood tests require specific minimum volumes. Diluting a finger prick to run hundreds of tests introduces enormous error rates. The fundamental science was against them.

The Approach — Tools in Action

First Principles Ishikawa Diagram Pre-mortem Survivorship Bias

What went wrong — No one applied First Principles:

Investors and board members accepted Holmes's claims at face value. No one asked the First Principles questions:

"What volume of blood is physically required for accurate results on each test?" → Many tests need milliliters, not microliters
"What are the error rates when you dilute a small sample?" → They increase dramatically
"Has this been validated in peer-reviewed research?" → No
"Can we speak to the scientists building this?" → Holmes refused, citing "trade secrets"

If any investor had applied First Principles thinking — breaking the claim down to fundamental physical and chemical realities — the fraud would have been obvious years earlier.

What they needed — Ishikawa Diagram (root cause analysis):

When early test results showed inaccurate readings, an Ishikawa Diagram would have traced the root causes:

Technology: The Edison device diluted samples beyond usable levels
Process: Theranos secretly ran most tests on standard Siemens machines (not their own)
People: Scientists who raised concerns were fired or silenced
Environment: A culture of secrecy prevented any independent validation

Pre-mortem thinking was deliberately suppressed. Anyone who said "What if this technology doesn't work?" was fired. Holmes created a culture where questioning the vision was treated as disloyalty — the exact opposite of a healthy Pre-mortem culture.

The Outcome

The fraud unraveled completely:

Theranos's peak valuation of $9 billion dropped to zero
Elizabeth Holmes was convicted of fraud in January 2022 and sentenced to prison
Patients received inaccurate test results, some of which led to misdiagnoses
The Theranos board included Henry Kissinger, George Shultz, and Jim Mattis — none of whom had biotech expertise to challenge the claims
The fraud was exposed by Wall Street Journal reporter John Carreyrou, who did what the board should have done: asked basic First Principles questions

The contrast with legitimate biotech: Companies like Moderna and BioNTech subjected their mRNA technology to rigorous peer review, published research, and independent validation. First Principles thinking was embedded in their process. Theranos deliberately avoided all of it.

💡

Key Takeaway

The more revolutionary a claim, the more important it is to apply First Principles thinking. Break the claim down to fundamental physical realities. If the proponent refuses to let you examine the fundamentals — citing "trade secrets" or "vision" — that's the biggest red flag of all.